Literature DB >> 6609011

Development of simple standard assay procedures for the characterization of snake venom.

R D Theakston, H A Reid.   

Abstract

In accordance with the recommendations of the report of a WHO Coordination Meeting on Venoms and Antivenoms, methods have been developed for the assessment of lethal, defibrinogenating, procoagulant, haemorrhagic, and necrotizing properties of venoms, and used to study 53 venoms from 30 different species of snakes of medical importance throughout the world. The venoms studied included Echis carinatus (Iran), Naja naja kaouthia (Thailand), Notechis scutatus (Australia), Trimeresurus flavoviridis (Japan), Vipera russelli (Thailand), and Crotalus atrox (USA), which comprise six of the eight venoms designated by WHO as international reference venoms (IRVs). (C. atrox venom replaced C. adamanteus venom, as an adequate supply of the latter was not available.) The tests used were simple and should be reproducible in other laboratories throughout the world. Procedures for assaying neuromuscular paralytic activity and systemic myotoxic activity have yet to be developed.The tests will be used to assay the neutralizing potency of both international standard antivenoms (raised using the IRVs) and new and currently available commercial antivenoms. Such studies should result in the production of more potent antivenoms for use in both developing and developed countries, and improve the understanding and management of snake bite throughout the world.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6609011      PMCID: PMC2536230     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  7 in total

1.  Clinical effects of bites by Malayan viper (Ancistrodon rhodostoma).

Authors:  H A REID; P C THEAN; K E CHAN; A R BAHAROM
Journal:  Lancet       Date:  1963-03-23       Impact factor: 79.321

2.  Prolonged coagulation defect (defibrination syndrome) in Malayan viper bite.

Authors:  H A REID; K E CHAN; P C THEAN
Journal:  Lancet       Date:  1963-03-23       Impact factor: 79.321

3.  A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test).

Authors:  C VERMYLEN; R A DE VREKER; M VERSTRAETE
Journal:  Clin Chim Acta       Date:  1963-05       Impact factor: 3.786

4.  Intraspecies variability of the venom of Echis carinatus.

Authors:  E Tãborskã
Journal:  Physiol Bohemoslov       Date:  1971

5.  Bites by the saw-scaled or carpet viper (Echis carinatus): trial of two specific antivenoms.

Authors:  D A Warrell; N M Davidson; L D Omerod; H M Pope; B J Watkins; B M Greenwood; H A Ried
Journal:  Br Med J       Date:  1974-11-23

6.  The isolation and properties of the thrombin-like activity from Ancistrodon rhodostoma venom.

Authors:  M P Esnouf; G W Tunnah
Journal:  Br J Haematol       Date:  1967-07       Impact factor: 6.998

7.  Changes in coagulation effects by venoms of Crotalus atrox as snakes age.

Authors:  H A Reid; R D Theakston
Journal:  Am J Trop Med Hyg       Date:  1978-09       Impact factor: 2.345

  7 in total
  74 in total

1.  Antibody from mice immunized with DNA encoding the carboxyl-disintegrin and cysteine-rich domain (JD9) of the haemorrhagic metalloprotease, Jararhagin, inhibits the main lethal component of viper venom.

Authors:  R A Harrison; A M Moura-Da-Silva; G D Laing; Y Wu; A Richards; A Broadhead; A E Bianco; R D Theakston
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa.

Authors:  Juan J Calvete; Pedro Cid; Libia Sanz; Alvaro Segura; Mauren Villalta; María Herrera; Guillermo León; Robert Harrison; Nandul Durfa; Abdusalami Nasidi; R David G Theakston; David A Warrell; José María Gutiérrez
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

3.  A rapid and sensitive fluorometric method for the quantitative analysis of snake venom metalloproteases and their inhibitors.

Authors:  J E Biardi; K T Nguyen; S Lander; M Whitley; K P Nambiar
Journal:  Toxicon       Date:  2010-12-25       Impact factor: 3.033

4.  Coevolution of diet and prey-specific venom activity supports the role of selection in snake venom evolution.

Authors:  Axel Barlow; Catharine E Pook; Robert A Harrison; Wolfgang Wüster
Journal:  Proc Biol Sci       Date:  2009-04-01       Impact factor: 5.349

5.  Medically important differences in snake venom composition are dictated by distinct postgenomic mechanisms.

Authors:  Nicholas R Casewell; Simon C Wagstaff; Wolfgang Wüster; Darren A N Cook; Fiona M S Bolton; Sarah I King; Davinia Pla; Libia Sanz; Juan J Calvete; Robert A Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-09       Impact factor: 11.205

6.  The management of snake bite.

Authors:  H A Reid; R D Theakston
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

7.  Antivenom potential of ethanolic extract of Cordia macleodii bark against Naja venom.

Authors:  Pranay Soni; Surendra H Bodakhe
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

8.  The effects of specific antibody fragments on the 'irreversible' neurotoxicity induced by Brown snake (Pseudonaja) venom.

Authors:  R G Jones; L Lee; J Landon
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

9.  In silico identification of viper phospholipaseA2 inhibitors: validation by in vitro, in vivo studies.

Authors:  Amit Nargotra; Sujata Sharma; Mohd Iqbal Alam; Zabeer Ahmed; Asha Bhagat; Subhash Chander Taneja; Ghulam Nabi Qazi; Surrinder Koul
Journal:  J Mol Model       Date:  2011-03-01       Impact factor: 1.810

10.  Study on development of Vipera lebetina snake anti-venom in chicken egg yolk for passive immunization.

Authors:  Hossein Zolfagharian; Naser Mohammadpour Dounighi
Journal:  Hum Vaccin Immunother       Date:  2015-02-20       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.